Freedom Capital Markets maintains Buy rating on Nutex Health, $306 price target
Freedom Capital Markets maintained their Buy rating on Nutex Health's stock with a price target of $306.00.The price target implies an upside of 49.6% from the Sep 24 close of $204.59.Key takeaways from the analyst noteStrong Financial Metrics: Nutex Health demonstrates compelling financial perform…